Baker Bros. Advisors Reduces Exposure to MEI Pharma Inc (MEIP) to 3.4%

Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares revealed as held earlier. According to the filing with the Securities and Exchange Commission, Baker Bros. holds 3.4% of the company’s common stock, down from 5.1% held previously. Overall, in several deals, Baker Bros. Raised its position MEI Pharma, from 345,317 shares owned at the end of the third quarter of 2013.

MEI Pharma

MEI Pharma a development-stage oncology company; develops drugs for the treatment of cancer. Recently MEI Pharma Inc (NASDAQ:MEIP) priced an underwritten public offering of 4.38 million shares of its common stock at an offering price of $8.00 per share. The total gross proceeds of $35 million from the offering will be used to further the progress of clinical development programs for its drug candidates, Pracinostat, ME-344 and PWT143.

Recently, Deerfield Management, run by James E. Flynn, increased its holdings in MEI Pharma Inc (NASDAQ:MEIP) from 822,199 shares to 1.4 million shares representing 6.38% of the company. Jacob Gottlieb and his fund Visium Asset Management disclosed in October that the fund has amassed 931,767 shares of MEI Pharma representing 5.4% of the company. Nine Chapters Capital Management, led by Chao Ku, initiated a position in the stock in the third quarter of 2013 and holds 55,100 shares worth $1.54 million.

Julian and Felix Baker’s Baker Bros. Advisors focuses mainly on biotechnology companies. Recently the fund had raised its stake in Seattle Genetics, Inc. (NASDAQ:SGEN) from 20.5 million shares to 20.9 million shares, the stake included 112,500 shares under options, held directly by Felix Baker representing a 17.1% stake in the company’s common stock. Earlier in the first week of December, the fund had bought an additional 1.0 million shares of Seattle Genetics.

Julian and Felix Baker earlier had reduced its stake in Incyte Corporation (NASDAQ:INCY) from 30.20 million to 19.53 million shares and holds 11.8% in the company. The fund’s majority of the holding constitute of Pharmacyclics Inc (NASDAQ:PCYC) which constitute 9.01 million shares worth $1.25 billion.

Disclosure: none

Recommended Reading:

Empire Capital Management Adds Veeva Systems Inc (VEEV) to Its Equity Portfolio

SAC Capital Ups Stake in Crocs, Inc. (CROX)

Warren Buffett Reveals Holding 30.5% of USG Corporation (USG)’s Stock

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!